Need Help?

This is the dataset for the study "Liquid Biopsy-informed Precision Oncology Study to Evaluate the Clinical Utility of Non-invasive Genomic Profiling for Cancer Treatment Selection"

This dataset pertains to the study of the first planned analysis of an observational trial assessing the clinical utility of serial LB, combined with precision oncology recommendations by a molecular tumor board (MTB). 50 patients were enrolled between March 2023 and July 2024. The dataset includes 129 BAM files from the targeted capture. 84 samples are from cfDNA, and 45 are from matched buffy coat.

Request Access

DUO:0000018
version: 2021-02-23

not for profit, non commercial use only

This data use modifier indicates that use of the data is limited to not-for-profit organizations and not-for-profit use, non-commercial use.

DUO:0000021
version: 2021-02-23

ethics approval required

This data use modifier indicates that the requestor must provide documentation of local IRB/ERB approval.

DUO:0000026
version: 2021-02-23

user specific restriction

This data use modifier indicates that use is limited to use by approved users.

DUO:0000027
version: 2021-02-23

project specific restriction

This data use modifier indicates that use is limited to use within an approved project.

Policy for study "Liquid Biopsy-informed Precision Oncology Study to Evaluate the Clinical Utility of Non-invasive Genomic Profiling for Cancer Treatment Selection"

This Data Access Agreement (“Agreement” or “DAA”), including its appendices, is to allow User Institution and its Authorized Personnel to access and use the Data from Johns Hopkins University (“Provider”) for the Project. Provider is willing to allow User Institution to access such Data from the European Genome-Phenome Archive (“EGA”) for use solely for the research purposes described in Appendix II, wherein User Institution may not use the Data for any commercial purpose. The User Institution agrees to be bound by the terms and conditions of this Agreement. This Agreement is effective as of the data of last signature below. These terms and conditions govern access to the managed access datasets (details of which are set out in Appendix I) to which the User Institution has requested access. The User Institution agrees to be bound by these terms and conditions. Definitions DAC: The data access committee for “Liquid Biopsy-informed Precision Oncology Study to Evaluate the Clinical Utility of Non-invasive Genomic Profiling for Cancer Treatment Selection”, EGA DAC EGAC50000001165. The DAC is comprised of Dr. Valsamo Anagnostou and can be contacted at vanagno1@jhmi.edu. Authorised Personnel: The individuals at the User Institution to whom the DAC grants access to the Data. This includes the User, the individuals listed in Appendix II and any other individuals for whom the User Institution subsequently requests access to the Data. Details of the initial Authorised Personnel are set out in Appendix II. Data: The managed access datasets to which the User Institution has requested access. Data Producers: The DAC and the collaborators listed in Appendix I responsible for the development, organisation, and oversight of these Data. External Collaborator: A collaborator of the User, working for an institution other than the User Institution. Project: The project for which the User Institution has requested access to these Data. A description of the Project is set out in Appendix II. Publications: Includes, without limitation, articles published in print journals, electronic journals, reviews, books, posters and other written and verbal presentations of research. Research Participant: An individual whose data form part of these Data. Research Purposes: Shall mean research that is seeking to advance the understanding of genetics and genomics, including the treatment of disorders, and work on statistical methods that may be applied to such research. User: The principal investigator for the Project. User Institution(s): The Institution that has requested access to the Data. Please include your Institution details here: 1. The User Institution agrees to only use these Data for the purpose of the Project (described in Appendix II) and only for Research Purposes. The User Institution further agrees that it will only use these Data for Research Purposes which are within the limitations (if any) set out in Appendix I. 2. The User Institution agrees to preserve, at all times, the confidentiality of these Data. In particular, it undertakes not to use, or attempt to use these Data to compromise or otherwise infringe the confidentiality of information on Research Participants. Without prejudice to the generality of the foregoing, the User Institution agrees to use at least the measures set out in Appendix I to protect these Data. 3. The User Institution agrees to protect the confidentiality of Research Participants in any research papers or publications that they prepare by taking all reasonable care to limit the possibility of identification. 4. The User Institution agrees not to link or combine these Data to other information or archived data available in a way that could re-identify the Research Participants, even if access to that data has been formally granted to the User Institution or is freely available without restriction. Should User Institution inadvertently receive identifiable information or otherwise identify a subject, Recipient shall promptly notify Provider and follow Data Producer’s reasonable written instructions, which may include return or destruction of the identifiable information. 5. The User Institution agrees only to transfer or disclose these Data, in whole or part, or any material derived from these Data, to the Authorised Personnel. Should the User Institution wish to share these Data with an External Collaborator, the External Collaborator must complete a separate application for access to these Data. 6. The User Institution agrees that the Data Producers, and all other parties involved in the creation, funding or protection of these Data: a) make no warranty or representation, express or implied as to the accuracy, quality or comprehensiveness of these Data; b) exclude to the fullest extent permitted by law all liability for actions, claims, proceedings, demands, losses (including but not limited to loss of profit), costs, awards damages and payments made by the Recipient that may arise (whether directly or indirectly) in any way whatsoever from the Recipient’s use of these Data or from the unavailability of, or break in access to, these Data for whatever reason and; c) bear no responsibility for the further analysis or interpretation of these Data. 7. The User Institution agrees to follow the Fort Lauderdale Guidelines (http://www.wellcome.ac.uk/stellent/groups/corporatesite/@policy_communications/documents/web_document/wtd003207.pdf ) and the Toronto Statement (http://www.nature.com/nature/journal/v461/n7261/full/461168a.html). This includes but is not limited to recognising the contribution of the Data Producers and including a proper acknowledgement in all reports or publications resulting from the use of these Data. Nothing herein shall authorize the User Institution to use or further disclose the Data in a manner that would violate the requirements of Data Producers under U.S. law, including 45 CFR 164.514. 8. The User Institution agrees to follow the Publication Policy in Appendix III. This includes respecting the moratorium period for the Data Producers to publish the first peer-reviewed report describing and analysing these Data. 9. The User Institution agrees not to make intellectual property claims on these Data and not to use intellectual property protection in ways that would prevent or block access to, or use of, any element of these Data, or conclusion drawn directly from these Data. 10. The User Institution can elect to perform further research that would add intellectual and resource capital to these data and decide to obtain intellectual property rights on these downstream discoveries. In this case, the User Institution agrees to implement licensing policies that will not obstruct further research and to follow the U.S. National Institutes of Health Best Practices for the Licensing of Genomic Inventions (2005) (https://www.icgc.org/files/daco/NIH_BestPracticesLicensingGenomicInventions_2005_en.pdf ) in conformity with the Organisation for Economic Co-operation and Development Guidelines for the Licensing of the Genetic Inventions (2006) (http://www.oecd.org/science/biotech/36198812.pdf ). 11. The User Institution agrees to destroy/discard the Data held, once it is no longer used for the Project, unless obliged to retain the data for archival purposes in conformity with audit or legal requirements. 12. The User Institution will notify the DAC within 30 days of any changes or departures of Authorised Personnel. 13. The User Institution will notify the DAC prior to any significant changes to the protocol for the Project. 14. The User Institution will notify the DAC as soon as it becomes aware of a breach of the terms or conditions of this agreement. 15. The DAC may terminate this agreement by written notice to the User Institution. If this agreement terminates for any reason, the User Institution will be required to destroy any Data held, including copies and backup copies. This clause does not prevent the User Institution from retaining these data for archival purpose in conformity with audit or legal requirements. 16. The User Institution accepts that it may be necessary for the Data Producers to alter the terms of this agreement from time to time. As an example, this may include specific provisions relating to the Data required by Data Producers other than the DAC. In the event that changes are required, the Data Producers or their appointed agent will contact the User Institution to inform it of the changes and the User Institution may elect to accept the changes or terminate the agreement. 17. If requested, the User Institution will allow data security and management documentation to be inspected to verify that it is complying with the terms of this agreement. 18. The User Institution agrees to distribute a copy of these terms to the Authorised Personnel. The User Institution will procure that the Authorised Personnel comply with the terms of this agreement. 19. If the Data Producer is a HIPAA Covered Entity, and if the the Data will be a Limited Data Set as defined by the Health Insurance Portability and Accountability Act of 1996 (“HIPAA”). In accordance with Section 164.514(e)(2) of the HIPAA Privacy Rule, the Data shall exclude the following direct identifiers of the individual or of relatives, employers, or household members of the individual: (i) Names; (ii) Postal address information, other than town or city, State, and zip code; (iii) Telephone numbers; (iv) Fax numbers; (v) Electronic mail addresses; (vi) Social security numbers; (vii) Medical record numbers; (viii) Health plan beneficiary numbers; (ix) Account numbers; (x) Certificate/license numbers; (xi) Vehicle identifiers and serial numbers, including license plate numbers; (xii) Device identifiers and serial numbers; (xiii) Web Universal Resource Locators (URLs); (xiv) Internet Protocol (IP) address numbers; (xv) Biometric identifiers, including finger and voice prints; and (xvi) Full face photographic images and any comparable images. If the Data being provided is coded, the Data Producer will not release, and the User Institution will not request, the key to the code. 20. The User Institution agrees to cite the publication(s) from which the Data are derived to acknowledge the version of the data and the contribution of the Data Producers in all reports or publications resulting from the use of the Data. The full citation(s) of the Data generating publication(s) and suggested acknowledgement are in Appendix IV.

Studies are experimental investigations of a particular phenomenon, e.g., case-control studies on a particular trait or cancer research projects reporting matching cancer normal genomes from patients.

Study ID Study Title Study Type
EGAS50000002145 Cancer Genomics

This table displays only public information pertaining to the files in the dataset. If you wish to access this dataset, please submit a request. If you already have access to these data files, please consult the download documentation.

ID File Type Size Quality Report
Located in
EGAF00009243782 bam 5.0 GB
EGAF00009243784 bam 5.9 GB
EGAF00009243785 bam 5.7 GB
EGAF00009243786 bam 4.7 GB
EGAF00009243787 bam 6.6 GB
EGAF00009243789 bam 6.0 GB
EGAF00009243790 bam 6.4 GB
EGAF00009243791 bam 6.3 GB
EGAF00009243792 bam 6.1 GB
EGAF00009243794 bam 5.8 GB
EGAF00009243797 bam 6.3 GB
EGAF00009243798 bam 6.2 GB
EGAF00009243800 bam 6.0 GB
EGAF00009243801 bam 5.7 GB
EGAF00009243804 bam 6.1 GB
EGAF00009243810 bam 5.4 GB
EGAF00009243816 bam 5.7 GB
EGAF00009243820 bam 4.8 GB
EGAF00009243821 bam 5.7 GB
EGAF00009243822 bam 20.9 GB
EGAF00009243825 bam 23.9 GB
EGAF00009243826 bam 5.4 GB
EGAF00009243827 bam 5.6 GB
EGAF00009243829 bam 5.4 GB
EGAF00009243832 bam 21.5 GB
EGAF00009243833 bam 6.4 GB
EGAF00009243834 bam 26.7 GB
EGAF00009243836 bam 5.8 GB
EGAF00009243837 bam 4.6 GB
EGAF00009243839 bam 19.2 GB
EGAF00009243841 bam 22.2 GB
EGAF00009243846 bam 5.4 GB
EGAF00009243847 bam 6.2 GB
EGAF00009243851 bam 5.0 GB
EGAF00009243854 bam 4.4 GB
EGAF00009243861 bam 5.6 GB
EGAF00009243863 bam 27.9 GB
EGAF00009243864 bam 22.4 GB
EGAF00009243867 bam 5.2 GB
EGAF00009243868 bam 28.2 GB
EGAF00009243869 bam 6.7 GB
EGAF00009243870 bam 6.1 GB
EGAF00009243871 bam 5.2 GB
EGAF00009243873 bam 28.3 GB
EGAF00009243874 bam 5.1 GB
EGAF00009243876 bam 25.8 GB
EGAF00009243877 bam 5.8 GB
EGAF00009243879 bam 6.0 GB
EGAF00009243880 bam 28.9 GB
EGAF00009243881 bam 5.0 GB
EGAF00009243882 bam 29.3 GB
EGAF00009243883 bam 27.1 GB
EGAF00009243884 bam 5.4 GB
EGAF00009243885 bam 6.5 GB
EGAF00009243887 bam 5.6 GB
EGAF00009243888 bam 5.0 GB
EGAF00009243894 bam 4.6 GB
EGAF00009243896 bam 25.6 GB
EGAF00009243897 bam 5.1 GB
EGAF00009243898 bam 5.0 GB
EGAF00009243899 bam 6.0 GB
EGAF00009243901 bam 5.6 GB
EGAF00009243902 bam 5.9 GB
EGAF00009243903 bam 26.3 GB
EGAF00009243905 bam 5.3 GB
EGAF00009243907 bam 5.6 GB
EGAF00009243908 bam 26.9 GB
EGAF00009243911 bam 22.0 GB
EGAF00009243912 bam 28.2 GB
EGAF00009243913 bam 5.6 GB
EGAF00009243915 bam 5.3 GB
EGAF00009243920 bam 5.9 GB
EGAF00009243922 bam 5.4 GB
EGAF00009243923 bam 5.3 GB
EGAF00009243924 bam 4.9 GB
EGAF00009243926 bam 22.7 GB
EGAF00009243928 bam 6.1 GB
EGAF00009243929 bam 25.8 GB
EGAF00009243931 bam 28.0 GB
EGAF00009243932 bam 23.6 GB
EGAF00009243933 bam 5.7 GB
EGAF00009243937 bam 24.6 GB
EGAF00009243938 bam 5.2 GB
EGAF00009243942 bam 5.1 GB
EGAF00009243943 bam 26.0 GB
EGAF00009243944 bam 21.5 GB
EGAF00009243945 bam 22.8 GB
EGAF00009243946 bam 5.6 GB
EGAF00009243947 bam 6.2 GB
EGAF00009243948 bam 5.3 GB
EGAF00009243949 bam 25.4 GB
EGAF00009243950 bam 24.1 GB
EGAF00009243951 bam 5.1 GB
EGAF00009243952 bam 5.0 GB
EGAF00009243953 bam 22.8 GB
EGAF00009243955 bam 5.4 GB
EGAF00009243956 bam 24.4 GB
EGAF00009243957 bam 5.7 GB
EGAF00009243958 bam 20.5 GB
EGAF00009243959 bam 28.5 GB
EGAF00009243963 bam 28.0 GB
EGAF00009243966 bam 5.8 GB
EGAF00009243967 bam 24.6 GB
EGAF00009243970 bam 22.9 GB
EGAF00009243973 bam 5.0 GB
EGAF00009243974 bam 25.3 GB
EGAF00009243975 bam 4.9 GB
EGAF00009243980 bam 19.0 GB
EGAF00009243981 bam 25.8 GB
EGAF00009243982 bam 5.4 GB
EGAF00009243983 bam 22.1 GB
EGAF00009243984 bam 5.1 GB
EGAF00009243985 bam 21.3 GB
EGAF00009243992 bam 23.6 GB
EGAF00009243994 bam 5.3 GB
EGAF00009243997 bam 5.7 GB
EGAF00009244001 bam 5.0 GB
EGAF00009244003 bam 5.4 GB
EGAF00009244006 bam 5.2 GB
EGAF00009244007 bam 6.2 GB
EGAF00009244008 bam 5.7 GB
EGAF00009244009 bam 5.6 GB
EGAF00009244010 bam 5.1 GB
EGAF00009244011 bam 5.6 GB
EGAF00009244012 bam 19.8 GB
EGAF00009244013 bam 5.6 GB
EGAF00009244014 bam 4.9 GB
EGAF00009244015 bam 25.6 GB
EGAF00009244016 bam 23.8 GB
129 Files (1.6 TB)